"Investigators have pinpointed a molecular defect that seems almost universal among patients with Parkinson's disease and those at a high risk of acquiring it......The scientists also identified a compound that appears to reverse the defect in cells taken from Parkinson's patients. In animal models of the disease, the compound prevented the death of the neurons whose loss underlies the disease."
Potential Diagnostic Tool, Treatment for PD - Cure Parkinson's
Potential Diagnostic Tool, Treatment for PD

Written by

Rebtar
To view profiles and participate in discussions please or .
8 Replies
•
Most interesting article. A ray of Hope. Too late for me but not for many new Parkinson's people. I really hope something's going to happen so this can be developed.
Thanks for sharing.
These articles allow me to see my problem so much more clearly now.
I was born 10 years too soon.
Very interesting and I like how it was explained for us laymen by illustrations that made perfect sense. Sounds promising in the future...maybe not back to the future but nothing's perfect.
Thanks for sharing this! I'm sure I read this when you first posted it, but I somehow found this post again and was filled with some much needed hope. I just wish the pace of research could be expedited.
Not what you're looking for?
You may also like...
Parkibot - AI for PD
Hi fellow Parkies. Please check out the new free ParkiBot, an AI created for the Parkinson's...
I asked Chat GPT what the best supplements to take for PD
Artificial Intelligence?? Pretty pedestrian intelligence if you ask me.
"As an AI language...
Parkinson's breakthrough could be on horizon, pre-clinical study shows
Purdue University researchers say they have pinpointed how the compound acrolein promotes the...
Gut Microbiota Dysfunction - Early Diagnostic Biomarkers in PD
Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the...
Potential disease-modifying therapy enters Phase 2
"Following the review of the data of the 101 trial, the drug advanced to the Phase II 201 trial...